A detailed history of Johnson Investment Counsel Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 4,952 shares of RDY stock, worth $78,192. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,952
Previous 4,952 -0.0%
Holding current value
$78,192
Previous $377,000 4.24%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$67.36 - $77.59 $78,137 - $90,004
1,160 Added 30.59%
4,952 $363,000
Q1 2023

May 15, 2023

BUY
$51.63 - $56.93 $195,780 - $215,878
3,792 New
3,792 $215,000
Q2 2020

Aug 13, 2020

BUY
$39.55 - $54.65 $149,973 - $207,232
3,792 New
3,792 $201,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.62B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.